Systematic review of risk factors and outcomes of post- implantation syndrome following endovascular aortic repair

被引:2
作者
D'Oria, Mario [1 ]
Manoranjithan, Shaminy [2 ]
Scoville, Caryn [3 ]
Vogel, Todd R. [4 ]
Cheung, Steven [4 ]
Calvagna, Cristiano [1 ]
Lepidi, Sandro [1 ,4 ]
Bath, Jonathan [4 ]
机构
[1] Univ Hosp Trieste ASUGI, Cardiovasc Dept, Div Vasc & Endovasc Surg, Trieste, Italy
[2] Univ Missouri, Sch Med, Columbia, MO USA
[3] Univ Missouri, Hlth Sci Lib, Columbia, MO USA
[4] Univ Missouri, Div Vasc Surg, 1 Hosp Dr, Columbia, MO 65212 USA
关键词
Endovascular aneurysm repair; EVAR; PIS; Post-implantation syndrome; POSTIMPLANTATION SYNDROME; INFLAMMATORY RESPONSE; ANEURYSM REPAIR; GRAFT; EVAR; IMPACT; PROCALCITONIN; SURVEILLANCE; MORTALITY; SURGERY;
D O I
10.1016/j.jvs.2023.12.029
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Post implantation syndrome (PIS) is an early systemic inflammatory response following endovascular aortic repair (EVAR). The response is variable in patients and the clinical significance of PIS upon outcomes is unknown. This study aims to evaluate the incidence, risk factors, and prognostic implication of PIS. Methods: Systematic literature review and analysis was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and Cochrane guidelines of PubMed, Scopus, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials. Eligible English-language studies regarding PIS after infrarenal EVAR were included, after removing duplicates. Results: After screening, 31 studies were included. A total of 2847 patients were reviewed, with mean age of 70.7 years, of which 2012 (90.4%) were male, with a pooled mean follow-up of 26.1 months. PIS was reported in 25.3% of cases, with mean aneurysm diameter of 56.4 cm. Polytetrafluoroethylene (PTFE) grafts were utilized in 794 patients (27.9%) with polyester in 1839 (64.6%). White blood cell count, C-reactive protein, interleukin (IL)-6, IL-8, and IL-10 levels were all significantly elevated postoperatively. Thirty-day outcomes included type I endoleak rate of 0.8%, type II endoleak rate of 1.7%, reintervention rate of 0.35%, and mortality rate of 0.25%. Subgroup pooled analysis of patients with PIS (n = 309) vs No-PIS (n = 691) revealed that polyester (n = 642), rather than PTFE (n = 234) grafts, were associated with a higher rate of PIS (94.8% vs 3.7%; P = .0001), White blood cell count was higher in the PIS group both preoperatively (7.61 vs 6.76 x 10(9)/L; P = .04) and postoperatively (15.0 vs 9.8 x 10(9)/L; P = .0007) and IL-6 levels were higher in the PIS group postoperatively (98.6 vs 25.2 pg/mL; P = .02). Aneurysm diameter and amount of chronic or new thrombus within the aneurysm sac was not identified as a risk factor for PIS. Pooled outcomes of patients with PIS vs No-PIS demonstrated a significantly higher rate of 30-day mortality (0.6% vs 0%; P = .03) and major adverse cardiac events (5.8% vs 0.43%; P < .0001) without any differences seen in reintervention or 30-day type I or type II endoleaks. Conclusions: This systematic review suggests that polyester grafts are strongly associated with PIS compared with PTFE. Interestingly, this report is suggestive of an association between 30-day mortality and major adverse cardiac events and PIS. Given these clinical sequelae, consideration for use of PTFE over polyester grafts to reduce the incidence of PIS may be a simple step to improve overall outcome. Further, exploration of the relationship between inflammatory mediators associated with PIS and mortality and cardiac complications may engender deeper understanding of risks, leading to eventual mitigation of harm for patients experiencing PIS.
引用
收藏
页数:15
相关论文
共 49 条
[11]   Early pyrexia after endovascular aneurysm repair: are cultures needed? [J].
Corfield, L. ;
Chan, J. ;
Chance, T. ;
Wilson, N. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (02) :111-113
[12]  
De La Motte L, 2011, J CARDIOVASC SURG, V52, P73
[13]   Preoperative Methylprednisolone Enhances Recovery After Endovascular Aortic Repair A Randomized, Double-Blind, Placebo-Controlled Clinical Trial [J].
de la Motte, Louise ;
Kehlet, Henrik ;
Vogt, Katja ;
Nielsen, Claus H. ;
Groenvall, John B. ;
Nielsen, Henning B. ;
Andersen, Andreas ;
Schroeder, Torben V. ;
Loenn, Lars .
ANNALS OF SURGERY, 2014, 260 (03) :540-549
[14]   Changes in TH1/TH2 immunity after endovascular and conventional infrarenal aortic aneurysm repair: Its relevance for clinical practice [J].
Decker, D ;
Springer, W ;
Decker, P ;
Tolba, R ;
Remig, J ;
Strunk, H ;
Hirner, A ;
von Ruecker, A .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 25 (03) :254-261
[15]  
Elmarasy NM, 2000, J ENDOVASC THER, V7, P21, DOI 10.1583/1545-1550(2000)007<0021:SIATIR>2.3.CO
[16]  
2
[17]   Long Term Outcomes of Post-Implantation Syndrome After Endovascular Aneurysm Repair [J].
Ferreira, Rita Soares ;
Oliveira-Pinto, Jose ;
Ultee, Klaas ;
Voute, Michiel T. ;
Oliveira, Nelson F. G. ;
Hoeks, Sanne ;
Verhagen, Hence J. M. ;
Goncalves, Frederico Bastos .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2021, 62 (04) :561-568
[18]  
Filardo G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001835.pub4, 10.1002/14651858.CD001835.pub3]
[19]   Analysis of the inflammatory response in endovascular treatment of aortic aneurysms [J].
Gabriel, Edmo Atique ;
Locali, Rafael Fagionato ;
Romano, Carta Cristina ;
da Silva Duarte, Alberto Jose ;
Palma, Jose Honrio ;
Buffolo, Enio .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (03) :406-412
[20]   Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair [J].
Gerasimidis, T ;
Sfyroeras, G ;
Trellopoulos, G ;
Skoura, L ;
Papazoglou, K ;
Konstantinidis, K ;
Karamanos, D ;
Filaktou, A ;
Parapanisiou, E .
ANGIOLOGY, 2005, 56 (06) :743-753